As opposed to its angiogenic isoforms, VEGFA also has inhibitory isoforms such as VEGFA165b, which are upregulated in obesity, counteracting the pro-angiogenic effects and promoting vascular rarefaction in the vWAT of patients with obesity [80]. The gene discussed is VEGFA; the disease is obesity disorder.